• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (125)

    Publication numberPublication dateAssigneeTitle
    US-2004057941-A1March 25, 2004Advisys, Inc., Baylor College Of MedicinePlasmid mediated supplementation for treating chronically ill subjects
    US-2005019311-A1January 27, 2005Holaday John W., Meserol Peter H., Doug Doerfler, Green Shawn J., Vininder SinghFlow electroporation chamber and method
    US-5763270-AJune 09, 1998Genemedicine, Inc.Plasmid for delivery of nucleic acids to cells and methods of use
    US-5614385-AMarch 25, 1997Creative Biomolecules, Inc.Methods and compositions for high protein production from recombinant DNA
    EP-3128048-A1February 08, 2017Janssen Biotech, Inc.Auf fibronectin-typ-iii-domain basierende gerüstzusammensetzungen, verfahren und verwendung
    US-2009292107-A1November 26, 2009Vgx Pharmaceuticlas, Inc.Composition and method to alter lean body mass and bone properties in a subject
    US-5720921-AFebruary 24, 1998Entremed, Inc.Flow electroporation chamber and method
    US-8563697-B2October 22, 2013Cephalon Australia Pty. Ltd.Anti-IL-12/IL-23 antibodies
    US-7547551-B2June 16, 2009University Of Antwerp., Gerold Schuler, Isolde StrobelTransfection of eukaryontic cells with linear polynucleotides by electroporation
    US-9708410-B2July 18, 2017Janssen Biotech, Inc.Anti-tissue factor antibodies and compositions
    WO-2012109162-A1August 16, 2012Cerenis Therapeutics Holding S.A.Complexes de lipoprotéines, leur production et leurs utilisations
    WO-2017044424-A1March 16, 2017Theripion, Inc.Polypeptides de fusion apoa-1 ainsi que compositions et procédés associés
    EP-2256199-A1December 01, 2010ZymoGenetics, Inc.Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2
    EP-2123675-A2November 25, 2009Centocor Ortho Biotech Inc.Human EPO mimentic hinge core mimetibodies, compositions, methods and uses
    US-7338656-B2March 04, 2008Baylor College Of MedicineComposition and method to alter lean body mass and bone properties in a subject
    US-2006292554-A1December 28, 2006Genentech, Inc.Major coat protein variants for C-terminal and bi-terminal display
    WO-2017053423-A1March 30, 2017Erasmus University Medical Center, Surface Oncology, Inc.Anti-cd47 antibodies and methods of use
    US-7833529-B1November 16, 2010Zymogenetics, Inc.Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
    US-8685893-B2April 01, 2014Genentech, Inc.Phage display
    US-6156514-ADecember 05, 2000Sunol Molecular CorporationMethods for making recombinant cells
    US-7247475-B2July 24, 2007WyethMethod for producing monoclonal antibodies
    WO-2011123507-A1October 06, 2011Centocor Ortho Biotech Inc.Anticorps humanisés de il-25
    EP-2476706-A2July 18, 2012Bayer HealthCare LLCAnticorps anti-MN et leurs procédés d'utilisation
    EP-2295577-A2March 16, 2011ZymoGenetics, Inc.Menschliche Zytokine als Liganden des Z-Alpha-Rezeptors und Verwendungen davon
    US-7419660-B1September 02, 2008Genitope CorporationVaccines for treatment of lymphoma and leukemia
    US-8178504-B2May 15, 2012Vgx Pharmaceuticals, Inc.Gene therapy expression of GHRH for increasing RBC count in subjects
    EP-2452694-A1May 16, 2012Janssen Biotech, Inc.Anticorps anti-IL-23, compositions, procédés et utilisations
    US-5631158-AMay 20, 1997Creative Biomolecules, Inc.Methods and compositions for high protein production from non-native DNA
    EP-2305817-A2April 06, 2011Centocor Ortho Biotech Inc.Antikörper gegen IL-12, Zusammensetzungen, Verfahren und Verwendungen
    WO-2011156356-A1December 15, 2011Zymogenetics, Inc.Protéines de fusion vstm3 dimères et compositions et procédés connexes
    US-5612207-AMarch 18, 1997Cbr Laboratories, Inc.Method and apparatus for encapsulation of biologically-active substances in cells
    US-6306605-B1October 23, 2001Sunol Molecular CorporationMethods for making recombinant cells
    US-7241744-B2July 10, 2007Baylor College Of Medicine, Advisys, Inc.Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
    WO-2010051274-A2May 06, 2010Centocor Ortho Biotech Inc.Fibronectin type iii domain based scaffold compositions, methods and uses
    WO-2016085820-A1June 02, 2016Shire Human Genetic Therapies, Inc.Ciblage lysosomial et utilisations correspondantes
    US-8808696-B2August 19, 2014Ares Trading S.A., Zymogenetics, Inc.Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
    US-7011974-B2March 14, 2006WyethMethod for producing monoclonal antibodies
    US-7718176-B2May 18, 2010Cna Development LlcHuman EPO mimetic hinge core mimetibodies, compositions, methods and uses
    US-9546350-B2January 17, 2017Maxcyte, Inc.Methods and devices related to a regulated flow electroporation chamber
    WO-2017172771-A2October 05, 2017Janssen Biotech, Inc.Method of treating psoriasis with increased interval dosing of anti-il12/23 antibody
    US-2004038394-A1February 26, 2004Kim Jong-Mook, Jung-Seob Kim, Sun-Mo Oh, Jae-Seung Yoon, Kwang-Hee Baek, Soo-Il Chung, Doo-Hong Park, Yeup YoonExpression vector using for animal cell
    WO-2005097175-A2October 20, 2005Centocor, Inc.Human glp-1 mimetibodies, compositions, methods and uses
    EP-2194130-A1June 09, 2010ZymoGenetics, L.L.C.Cytokine ZCYTO18
    WO-2016070156-A2May 06, 2016Shire Human Genetic Therapies, Inc.Protéines de fusion de l'inhibiteur de la c1 estérase et leurs utilisations
    US-8784812-B2July 22, 2014Zymogenetics, Inc., Ares Trading S.A.Methods for treating autoimmune diseases using a TACI-Ig fusion molecule
    US-5658763-AAugust 19, 1997Creative Biomolecules, Inc.Methods and compositions for high protein production from non-native DNA
    US-7771984-B2August 10, 2010Maxcyte, Inc.Methods and devices related to a regulated flow electroporation chamber
    US-2009098108-A1April 16, 2009O'neil Karyn T, Kristen Picha, Vedrana Stojanovic-SusulicUse of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles
    US-5585237-ADecember 17, 1996Creative Biomolecules, Inc.Methods and compositions for high protein production from recombinant DNA
    US-2004115784-A1June 17, 2004Maxcyte, Inc.Apparatus and method for streaming electroporation
    WO-2004002417-A2January 08, 2004Centocor, Inc.Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
    EP-2389944-A1November 30, 2011ZymoGenetics, L.L.C., Bristol-Myers Squibb CompanyNutzung von IL-28 und IL-29 zur Behandlung von Krebs
    WO-2017087882-A1May 26, 2017Shire Human Genetic Therapies, Inc.Inhibiteur de la c1 estérase humaine recombinante et ses utilisations
    EP-2105446-A2September 30, 2009ZymoGenetics, Inc.Récepteur de cytokine zalpha11
    US-2011065171-A1March 17, 2011Sergey Dzekunov, Nicholas Chopas, Linhong LiMethods and devices related to a regulated flow electroporation chamber
    WO-2005087810-A2September 22, 2005Zymogenetics, Inc.Dimeric fusion proteins and materials and methods for producing them
    EP-2264175-A1December 22, 2010ZymoGenetics, L.L.C.Fibroblast growth factor homologs
    US-7405060-B2July 29, 2008Genitope CorporationGene amplification methods
    EP-2251352-A1November 17, 2010ZymoGenetics, L.L.C., Bristol-Myers Squibb CompanyHomogene Präparate von IL-28 und IL-29
    EP-2330129-A2June 08, 2011Centocor Ortho Biotech Inc.Anti-TNF antibodies, compositions, methods and uses
    EP-2604280-A2June 19, 2013ZymoGenetics, Inc.Compositions and methods for inhibiting PDGFRBETA and VEGF-A
    US-7842292-B2November 30, 2010Ares Trading S.A., Zymogenetics, Inc., Mayo Foundation For Medical Education And ResearchMethods for treating B-cell malignancies using a TACI-Ig fusion molecule
    US-2003119685-A1June 26, 2003The Procter & Gamble CompanyPersonal cleansing compositions comprising silicone resin-containing adhesives
    EP-2308888-A1April 13, 2011Centocor Ortho Biotech Inc.Anti-IL-6-Antikörper, Zusammensetzungen, Verfahren und Anwendungen
    EP-3118318-A1January 18, 2017Janssen Biotech, Inc.Anticorps anti-tnf, compositions, procédés et utilisations
    US-5733782-AMarch 31, 1998Creative Biomolecules, Inc.Methods and compositions for high protein production from non-native DNA
    EP-3219328-A1September 20, 2017Janssen Biotech, Inc.Compositions, procédés et utilisations d'anticorps humains anti-il-23
    US-2007135338-A1June 14, 2007Karyn O'neil, Kristen PichaHuman GLP-1 mimetibodies, compositions, methods and uses
    US-2005032737-A1February 10, 2005Advisys, Inc.Canine specific growth hormone releasing hormone
    WO-03049700-A2June 19, 2003Advisys, Inc., Baylor College Of MedicineSupplementation induite par les plasmides dans le traitement de maladies chroniques affectant des sujets
    EP-2623112-A1August 07, 2013Zymogenetics, Inc.Lösliche hybride FC-Gamma-Rezeptoren und zugehörige Verfahren
    US-2007071760-A1March 29, 2007Herve Broly, Arnaud Ythier, Eric Sievers, Busby Sharon J, Jan Ohrstrom, Ivan Nestorov, Ansell Stephen MMethods for treating B-cell malignancies using a TACI-Ig fusion molecule
    US-8822642-B2September 02, 2014Zymogenetics, Inc.Dimeric fusion proteins and related compositions and methods
    EP-2258725-A2December 08, 2010ZymoGenetics, L.L.C.Récepteur de la cytokine zcytor17
    US-2008221034-A1September 11, 2008Vgx Pharmaceuticals, Inc.Canine specific growth hormone releasing hormone
    US-7833531-B2November 16, 2010Centocor, Inc.Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists
    EP-2090657-A2August 19, 2009Centocor Ortho Biotech Inc.Anti-IL-12 antibodies, compositions, methods and uses
    US-2002160006-A1October 31, 2002Denney Dan W.Methods of treating lymphoma and leukemia
    EP-1988102-A1November 05, 2008ZymoGenetics, Inc.Growth factor homolog ZVEGF3
    EP-1757617-A1February 28, 2007Biogen Idec MA Inc.Ret Ligand (RetL) pour stimuler la croissance neurale et renale
    US-2008206754-A1August 28, 2008WyethMethod for producing monoclonal antibodies
    EP-2840089-A1February 25, 2015ZymoGenetics, Inc.Cytokine receptor zcytor17 multimers
    EP-2080766-A1July 22, 2009Bristol-Myers Squibb CompanyZur Immunmodulation nützliche B7-verwandte Nukleinsäuren und Polypeptide
    EP-2767546-A1August 20, 2014Cerenis Therapeutics Holding SALipoprotein complexes and manufacturing and uses therof
    US-2010034819-A1February 11, 2010Centocor Inc.Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemia
    US-5733753-AMarch 31, 1998Novo Nordisk A/SAmplification of genomic DNA by site specific integration of a selectable marker construct
    US-2002155540-A1October 24, 2002Malla PadidamMethod to reduce transcriptional interference between tandem genes
    US-2005004060-A1January 06, 2005Advisys, Inc.Plasmid mediated GHRH supplementation for renal failures
    EP-2132984-A2December 16, 2009ZymoGenetics, L.L.C., Bristol-Myers Squibb CompanyInterferon-like protein ZCYTO21
    US-5712119-AJanuary 27, 1998Creative Biomolecules, Inc.Methods and compositions for high protein production form recombinant DNA
    US-7422874-B2September 09, 2008Mogam Biotechnology Research Institute, Neurotech Pharmaceuticals Co., Ltd.Expression vector for animal cell
    US-6074605-AJune 13, 2000Entremed, Inc.Flow electroporation chamber and method
    US-2010249032-A1September 30, 2010Heavner George A, Knight David M, John Ghrayeb, Scallon Bernard J, Nesspor Thomas C, Chichi HuangHuman EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
    US-8481504-B2July 09, 2013Vgx Pharmaceuticals, Inc.Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
    US-2003143743-A1July 31, 2003Gerold Schuler, Berneman Zwi N., Van Tendeloo Viggo F. I., Peter Ponsaerts, Isolde StrobelTransfection of eukaryontic cells with linear polynucleotides by electroporation
    EP-2295455-A1March 16, 2011ZymoGenetics, L.L.C., Bristol-Myers Squibb CompanyCytokine receptor
    US-2003059945-A1March 27, 2003Dzekunov Sergey M., Lee Hyung J., Linhong Li, Vininder Singh, Linda Liu, Holaday John W.Apparatus and method for flow electroporation of biological samples
    US-7186559-B2March 06, 2007Maxcyte, Inc.Apparatus and method for electroporation of biological samples
    WO-0040716-A2July 13, 2000Zymogenetics, Inc.RECEPTEURS SOLUBLES BR43x2 ET PROCEDES D'UTILISATION
    US-2003073238-A1April 17, 2003Dzekunov Sergey M., Lee Hyung J., Linhong Li, Vininder Singh, Linda Liu, Holaday John W.Apparatus and method for electroporation of biological samples
    EP-2130919-A1December 09, 2009ZymoGenetics, Inc.IL-21-Antagonisten
    EP-2548577-A1January 23, 2013Janssen Biotech, Inc.Humane Anti-IL-23-Antikörper, Zusammensetzungen, Verfahren und Verwendungen
    US-2003157717-A1August 21, 2003Baylor College Of Medicine Texas Medical CenterLinear DNA fragments for gene expression
    EP-2339002-A1June 29, 2011ZymoGenetics, Inc.Fibroblast growth factor homologs
    US-2007274984-A1November 29, 2007Ares Trading S.A., Zymogenetics, Inc.Methods for treating autoimmune diseases using a taci-ig fusion molecule
    US-2005282200-A1December 22, 2005Maxcyte, Inc.Methods and devices related to a regulated flow electroporation chamber
    US-7772365-B2August 10, 2010Zymogenetics, Inc.Soluble receptor BR43x2
    WO-2016025523-A1February 18, 2016Shire Human Genetic Therapies, Inc.Lysosomal targeting and uses thereof
    EP-2338910-A1June 29, 2011ZymoGenetics, Inc.Zytokinrezeptor Zyctor17-Multimere
    US-7361642-B2April 22, 2008Vgx Pharmaceuticals, Inc.Canine specific growth hormone releasing hormone
    KR-20160116056-AOctober 06, 2016테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디항-il-12/il-23 항체
    EP-2604279-A1June 19, 2013ZymoGenetics, Inc.Compositions et procédés pour inhiber PDGFR-bêta et VEGF-A
    EP-2842968-A1March 04, 2015Janssen Biotech, Inc., Applied Molecular Evolution Inc.Anti-IL-6 antibodies, compositions, methods and uses
    EP-2253646-A1November 24, 2010Centocor Ortho Biotech Inc.Anti-dual integrin antibody and compositions and conjugates comprising said antibody
    WO-03038112-A2May 08, 2003Baylor College Of MedicineComposition et methode permettant de modifier la masse maigre et les proprietes osseuses d'un sujet
    US-2006141574-A1June 29, 2006WyethMethod for producing monoclonal antibodies
    US-7029916-B2April 18, 2006Maxcyte, Inc.Apparatus and method for flow electroporation of biological samples
    US-7141425-B2November 28, 2006Maxcyte, Inc.Apparatus and method for electroporation of biological samples
    US-6773669-B1August 10, 2004Maxcyte, Inc.Flow electroporation chamber and method
    EP-2159230-A1March 03, 2010Centocor Ortho Biotech Inc.Anti-TNF-Antikörper, Zusammensetzungen, Verfahren und Verwendungen
    EP-2230299-A1September 22, 2010ZymoGenetics, Inc.Nouveau ligand de cytokine ZCYTOR17
    EP-2251353-A1November 17, 2010ZymoGenetics, L.L.C., Bristol-Myers Squibb CompanyHomogeneous preparations of IL-28 and IL-29
    WO-2010093627-A2August 19, 2010Centocor Ortho Biotech Inc.Compositions supports à base du domaine de la fibronectine de type iii, procédés et utilisations
    US-2003153039-A1August 14, 2003WyethMethod for producing monoclonal antibodies